Salvia miltiorrhiza Bunge, which targets different pathways in the bone remodeling cycle, including activation of osteoblasts, inhibition of osteoclast generation, and degradation of collagen by cathepsin K, has been proven in clinical practice to have good anti-osteoporosis potential [139]. This evidence concerns the gene CTSK and osteoporosis.